Conmed (CNMD) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $47.20 --0%
EPS Growth %: -7.4%
Financial Fact:
Weighted average common shares Basic: 27.82M
Today's EPS Names:
GEHC, NPK, HOS, More
EPS Growth %: -7.4%
Financial Fact:
Weighted average common shares Basic: 27.82M
Today's EPS Names:
GEHC, NPK, HOS, More
Join SI Premium – FREE
Conmed (NYSE: CNMD) reported Q4 EPS of $1.07, $0.01 better than the analyst estimate of $1.06. Revenue for the quarter came in at $274 million versus the consensus estimate of $278.76 million.
GUIDANCE:
Conmed sees FY2022 EPS of $3.60-$3.85, versus the consensus of $3.74. Conmed sees FY2022 revenue of $1.075-1.125 billion, versus the consensus of $1.11 billion.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lennox (LII) Misses Q3 EPS by 52c, Beats on Revenue; Offers FY26 EPS Guidance
- Aon plc (AON) Tops Q3 EPS by 6c
- Smurfit Westrock Plc (SW) Misses Q3 EPS by 15c, Misses on Revenue
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
